Status:

Do Not Prescribe (DNP), Red

Decision Date:

July 2025

Comments

RED: NICE TA1077 - Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over (Decision date July 2025)

DNP: NICE TA1191 - Nemolizumab for treating moderate to severe prurigo nodularis (Decision date September 2026)

Do Not Prescribe (DNP) Drug Classifications

• 6: Have NICE guidance that recommends they should not be used

search again